[Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins]. 1985

J Croize, and P Le Noc, and A Bryskier, and J Robert

Bacteriostatic and bactericidal effects of three fluoroquinolones, norfloxacin, ofloxacin and pefloxacin, against 320 strains of Gram-negative bacilli were studied in vitro. For nalidixic acid-susceptible Enterobacteriaceae, susceptibility or resistance to second or third generation cephalosporins has no significant bearing on the MIC 90 of each of the three antibiotics. This is not so of nalidixic acid-resistant strains. All E. coli and K. pneumoniae strains are susceptible to the three quinolones (MIC 90 less than 3 mg/1); MICs 90 are higher for E. cloacae and S. marcescens; Serratia strains in particular have an MIC 90 greater than 6 mg/1. Nalidixic acid-susceptible Acinetobacter strains can be eliminated by ofloxacin or pefloxacin, whereas norfloxacin has the greatest activity against P. aeruginosa. We conclude that when multiresistant bacteria emerge, testing of susceptibility to the three quinolones studied may be useful.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009268 Nalidixic Acid A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE. Nalidixin,Nalidixate Sodium,Nalidixate Sodium Anhydrous,Nevigramon,Sodium Nalidixic Acid, Anhydrous,Sodium Nalidixic Acid, Monohydrate,Acid, Nalidixic,Anhydrous, Nalidixate Sodium,Sodium Anhydrous, Nalidixate,Sodium, Nalidixate
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D000150 Acinetobacter A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity. Herellea,Mima

Related Publications

J Croize, and P Le Noc, and A Bryskier, and J Robert
January 1992, Archives de l'Institut Pasteur d'Algerie. Institut Pasteur d'Algerie,
J Croize, and P Le Noc, and A Bryskier, and J Robert
January 1987, Drugs under experimental and clinical research,
J Croize, and P Le Noc, and A Bryskier, and J Robert
August 1985, The Journal of antimicrobial chemotherapy,
J Croize, and P Le Noc, and A Bryskier, and J Robert
September 1984, The Journal of antimicrobial chemotherapy,
J Croize, and P Le Noc, and A Bryskier, and J Robert
April 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
J Croize, and P Le Noc, and A Bryskier, and J Robert
August 1992, Diagnostic microbiology and infectious disease,
J Croize, and P Le Noc, and A Bryskier, and J Robert
January 1989, Cleveland Clinic journal of medicine,
J Croize, and P Le Noc, and A Bryskier, and J Robert
December 1986, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!